Healthcare Global Enterprises Limited has informed the Exchange regarding 'We refer to our letter to the stock exchanges dated 23 February 2025 regarding execution of the Share Purchase Agreement dated 23 February 2025 entered into by and amongst HealthCare Global Enterprises Limited ( Company ), Hector Asia Holdings II Pte. Ltd. ( Purchaser 1 ), KIA EBT II Scheme 1 ( Purchaser 1 ) (Purchaser 1 and Purchaser 2, collectively Purchasers ) and Aceso Company Pte. Ltd. ( Seller ) ( SPA ).Purchaser 1, together with persons acting in concert are undertaking an open offer to acquire up to 3,70,90,327 equity shares comprising of 26% of the expanded voting share capital of the Company ( Open Offer ) from the public shareholders of the Company. The intention of Seller to be reclassified from a shareholder in the Promoter category to the Public category has been disclosed in various disclosures relating to the Open Offer, including the public announcement dated 23 February 2025, detailed public statement dated 01 March 2025 and draft letter of offer dated 10 March 2025.The Seller has on 30 May 2025 transferred: (i) 7,16,77,991 equity shares of the Company to Purchaser 1; and (ii) 2,50,044 equity shares of the Company to Purchaser 2 (collectively, Share Transfer ).'.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts more than Nifty Microcap 250 and 2.0 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Healthcare Global Enterprises Limited (HCG) has updated on the share transfer linked to the Share Purchase Agreement signed on 23 February 2025 between the company, Hector Asia Holdings II Pte. Ltd., KIA EBT II Scheme 1 (collectively Purchasers), and Aceso Company Pte. Ltd. (Seller). On 30 May 2025, the Seller transferred 7,16,77,991 equity shares to Purchaser 1 and 2,50,044 equity shares to Purchaser 2. An open offer is underway to acquire up to 3,70,90,327 equity shares, representing 26% of the expanded voting share capital of the company, from public shareholders. The Seller (Aceso) will be reclassified from the Promoter category to the Public category following the transfer.
This is a significant change in ownership/promoter structure of HCG, with a new promoter group (Hector Asia / KIA) taking control and an open offer available to public shareholders at the offer price. Shareholders should review the open offer terms and consider their participation options.